LI’s Aceto Corp. to begin selling migraine drug
The Aceto Corp. headquarters in Port Washington. Credit: Barry Sloan
Aceto Corp. said Monday it plans to begin selling a medicine to treat migraines.
The Port Washington-based manufacturer of drugs and chemicals said it would launch zolmitriptan tablets, a generic version of Zomig from IPR Pharamaceuticals Inc.
The drug information provider IMS Health estimated U.S. sales of zolmitriptan totaled $49 million last year.
The generic drug will be sold by Aceto’s Rising Pharmaceuticals subsidiary, which is based in New Jersey.
Aceto made the announcement after the stock market opening. The company’s stock fell 13 cents to $23.46 on the Nasdaq Stock Market Monday.
Sarra Sounds Off, Ep. 15: LI's top basketball players On the latest episode of "Sarra Sounds Off," Newsday's Gregg Sarra and Matt Lindsay take a look top boys and girls basketball players on Long Island.
Sarra Sounds Off, Ep. 15: LI's top basketball players On the latest episode of "Sarra Sounds Off," Newsday's Gregg Sarra and Matt Lindsay take a look top boys and girls basketball players on Long Island.
